Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 10:45 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 865–888 of 3,255 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Device Clear all

Conditions: Breast Neoplasm
Interventions: ExoPred; Diagnostic Test
Lead sponsor: EXoPERT; Industry
Eligibility: 40 Years and older · Female only
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Cancer of Pancreas, Cancer of Pelvis, Cancer of Abdomen, Cancer of Thorax
Interventions: Ring gantry kV-CBCT combined with linear accelerator; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Endothelial Cells, Exercise Tolerance
Interventions: Not listed
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Metastatic Non-small Cell Lung Cancer, NSCLC
Interventions: Durvalumab, Tremelimumab, BI 1361849, PharmaJet Tropis® device; Drug · Biological · Device
Lead sponsor: Ludwig Institute for Cancer Research; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 5
States / cities: Gilbert, Arizona • Tampa, Florida • Detroit, Michigan + 2 more

Conditions: Cerebral Ischemia
Interventions: CDI 1000 COM; Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Orange, California

Conditions: Epilepsy
Interventions: Study Subjects; Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Colon Disease, Gastric Disease
Interventions: Tissue Access and Resection System; Procedure
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cardiovascular Disease
Interventions: Cyanoacrylate tissue adhesive (Dermabond), Polyglactin 910 suture (Vicryl); Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years and older
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Gastrointestinal Neoplasms
Interventions: Closure type; Procedure
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hair Removal
Interventions: Hair2Go; Device
Lead sponsor: Syneron Medical; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 3
States / cities: Tustin, California • Chicago, Illinois • Edina, Minnesota

Conditions: Breathing, Mouth, Lung Function Decreased, Vocal Cord Dysfunction, Laryngeal Obstruction, Asthma
Interventions: Impulse Oscillometer; Device
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Gestational Diabetes, Glucose Intolerance, Type 2 Diabetes, Intrauterine Contraception
Interventions: Mirena (Levonorgestrel IUD), Paragard (Copper IUD ) or Tubal Ligation; Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Peripheral Arterial Disease, Peripheral Neuropathy
Interventions: Replexa shortwave diathermy; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: GERD, Esophagitis
Interventions: Standard of care endoscopy; Procedure
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 429 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2021
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Low Vision
Interventions: Wearable Echolocation Device; Device
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 100 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Obesity
Interventions: IGEL, King airway; Device
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Intracranial Aneurysms
Interventions: Pipeline™ Flex Embolization Device with Shield Technology™; Device
Lead sponsor: Jacobs institute; Other
Eligibility: 22 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Liver Diseases, Healthy, Liver Cirrhosis, Liver Fibrosis
Interventions: Adult; Diagnostic Test
Lead sponsor: Group K Diagnostics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Spinal Cord Injuries
Interventions: TNM at a sham-point (AccelBand) - randomized arm, TNM at a leg point (AccelBand)- randomized arm, TNM at a leg point (AccelBand)- open-label; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Type2 Diabetes
Interventions: Continuous Glucose Monitor (CGM), Activity Tracker, Coaching; Device · Behavioral
Lead sponsor: Savvysherpa, Inc.; Industry
Eligibility: 65 Years and older
Enrollment: 358 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome
Interventions: Health Telemonitoring, Quality-of-Life Assessment, Questionnaire Administration, Supportive Care; Device · Other · Procedure
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Liver Cancer
Interventions: yttrium Y 90 glass microspheres; Radiation
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Healthy Volunteers, Adolescent
Interventions: PureWick System; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 12 Years to 21 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Fair Lawn, New Jersey

Conditions: Gastro Esophageal Reflux
Interventions: Esophyx; Device
Lead sponsor: Peter G Mavrelis; Individual
Eligibility: 18 Years to 80 Years
Enrollment: 99 participants
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: Merrillville, Indiana • Appleton, Wisconsin

Search by objective public record fields.

A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer

Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiotherapy Workflow in a Novel Ring Gantry Radiotherapy Device

Markers of Endothelial Function and Exercise CapaciTy in Patients With Left Ventricular Assist Devices (EFECT LVAD)

Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC

A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers

A Device to Prevent Unexpected Death in Epilepsy

Feasibility Trial to Evaluate the Ability of the SuMO Tissue Access and Resection System

Comparison of Cyanoacrylate Tissue Adhesive and Suture for Closure of Cardiac Device Pockets

Cost-effective Analysis of Two Approximation Devices in Closure of Gastrointestinal Defects

Long Term Efficiency of the Hair2Go Device

Evaluating the Use of a Device Called Impulse Oscillometry in Participants With Vocal Cord Disorders or Asthma

Postpartum Glucose Tolerance With Levonorgesterel IUD Use in Women With Recent Gestational Diabetes

Shortwave Diathermy In-home Treatment for Indianapolis VA-only Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy

Esophageal Monitoring Device for Assessing Mucosal Impedance

Wearable Echolocation Aids Using Parametric Sound

Use of New Supraglottic Airway Devices in Severely Obese Patients: A Feasibility Study

Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm

Blood Collection for Development and Validation of Point-of-Care Diagnostic Liver Function Tests

Efficacy of a Wearable Noninvasive Neuromodulation Device

Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3)

Telemonitoring Device in Managing Outpatient Care of Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia After Intensive Chemotherapy

Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

PureWick™ Adolescent Study

GERD Treatment With Transoral Incisionless Fundoplication (TIF) Following Hiatal Hernia Surgery